P

Inventor

HADWIGER PHILIPP

DE51 patents
⚠️ This page may combine multiple inventors who share the name “HADWIGER PHILIPP”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ALNYLAM PHARMACEUTICALS INC

21 patents
US7749978B2Jul 6, 2010

Compositions and methods for inhibiting expression of Huntingtin gene

ALNYLAM PHARMACEUTICALS INC113 citations99
US7320965B2Jan 22, 2008

Compositions and methods for inhibiting expression of Huntingtin gene

ALNYLAM PHARMACEUTICALS INC208 citations99
US7737265B2Jun 15, 2010

RNAi modulation of HIF-1 and therapeutic uses thereof

ALNYLAM PHARMACEUTICALS INC122 citations98
US7582745B2Sep 1, 2009

Compositions and methods for inhibiting expression of Nav1.8 gene

ALNYLAM PHARMACEUTICALS INC152 citations98
US7829693B2Nov 9, 2010

Compositions and methods for inhibiting expression of a target gene

ALNYLAM PHARMACEUTICALS INC134 citations97
US7786290B2Aug 31, 2010

Double-stranded ribonucleic acid with increased effectiveness in an organism

ALNYLAM PHARMACEUTICALS INC99 citations96
US7947659B2May 24, 2011

iRNA agents targeting VEGF

ALNYLAM PHARMACEUTICALS INC26 citations93
US7919473B2Apr 5, 2011

IRNA agents targeting VEGF

ALNYLAM PHARMACEUTICALS INC29 citations93
US7928217B2Apr 19, 2011

Nuclease resistant double-stranded ribonucleic acid

ALNYLAM PHARMACEUTICALS INC37 citations92
US7361752B2Apr 22, 2008

RNAi modulation of MLL-AF4 and uses thereof

ALNYLAM PHARMACEUTICALS INC14 citations92
US7528118B2May 5, 2009

RNAi modulation of ApoB and uses thereof

ALNYLAM PHARMACEUTICALS INC21 citations91
US8034793B2Oct 11, 2011

RNAi modulation of MLL-AF4 and uses thereof

ALNYLAM PHARMACEUTICALS INC10 citations84
US10131907B2Nov 20, 2018

Glycoconjugates of RNA interference agents

ALNYLAM PHARMACEUTICALS INC11 citations82
US7994307B2Aug 9, 2011

RNAi modulation of the BCR-ABL fusion gene and uses thereof

ALNYLAM PHARMACEUTICALS INC8 citations80
US7674779B2Mar 9, 2010

RNAi modulation of MLL-AF4 and uses thereof

ALNYLAM PHARMACEUTICALS INC5 citations73
US9587240B2Mar 7, 2017

Compositions and methods for inhibiting expression of a target gene

ALNYLAM PHARMACEUTICALS INC2 citations72
US7906484B2Mar 15, 2011

Complex for transferring an anionic substance into a cell

ALNYLAM PHARMACEUTICALS INC3 citations63
US9074213B2Jul 7, 2015

Compositions and methods for inhibiting expression of a target gene

ALNYLAM PHARMACEUTICALS INC2 citations62
US7902168B2Mar 8, 2011

Compositions and methods for inhibiting expression of Nav1.8 gene

ALNYLAM PHARMACEUTICALS INC1 citations52
US9187747B2Nov 17, 2015

RNAi modulation of ApoB and uses thereof

ALNYLAM PHARMACEUTICALS INC0 citations51
US7723317B2May 25, 2010

RNAi modulation of ApoB and uses thereof

ALNYLAM PHARMACEUTICALS INC0 citations51

ROZEMA DAVID B

4 patents

AXOLABS GMBH

4 patents

HOFFMANN LA ROCHE

3 patents

ARROWHEAD MADISON INC

2 patents

VORNLOCHER HANS-PETER

2 patents

MPEG LA LLC

2 patents

MPEG LA L L C

2 patents

SAH DINAH WEN-YEE

2 patents

KREUTZER ROLAND

1 patent

CONSTIEN RAINER

1 patent

ALNYLAM EUROPE AG

1 patent

FORST ANDREA

1 patent

DE FOUGEROLLES ANTONIN

1 patent

HADWIGER PHILIPP

1 patent

ARROWHEAD PHARMACEUTICALS INC

1 patent

SOUTSCHEK JUERGEN

1 patent

Showing the top 50 of 51 patents by PatentIndex Score.